Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.

Publication ,  Journal Article
Kumar, SK; Callander, NS; Adekola, K; Anderson, L; Baljevic, M; Campagnaro, E; Castillo, JJ; Chandler, JC; Costello, C; Efebera, Y; Faiman, M ...
Published in: J Natl Compr Canc Netw
December 2, 2020

Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

December 2, 2020

Volume

18

Issue

12

Start / End Page

1685 / 1717

Location

United States

Related Subject Headings

  • Plasmacytoma
  • Plasma Cells
  • Oncology & Carcinogenesis
  • Multiple Myeloma
  • Medical Oncology
  • Humans
  • Bone Marrow
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kumar, S. K., Callander, N. S., Adekola, K., Anderson, L., Baljevic, M., Campagnaro, E., … Kumar, R. (2020). Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(12), 1685–1717. https://doi.org/10.6004/jnccn.2020.0057
Kumar, Shaji K., Natalie S. Callander, Kehinde Adekola, Larry Anderson, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, et al. “Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 18, no. 12 (December 2, 2020): 1685–1717. https://doi.org/10.6004/jnccn.2020.0057.
Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, et al. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Dec 2;18(12):1685–717.
Kumar, Shaji K., et al. “Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw, vol. 18, no. 12, Dec. 2020, pp. 1685–717. Pubmed, doi:10.6004/jnccn.2020.0057.
Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Kang Y, Hultcrantz M, Larson S, Liedtke M, Martin T, Omel J, Shain K, Sborov D, Stockerl-Goldstein K, Weber D, Keller J, Kumar R. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Dec 2;18(12):1685–1717.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

December 2, 2020

Volume

18

Issue

12

Start / End Page

1685 / 1717

Location

United States

Related Subject Headings

  • Plasmacytoma
  • Plasma Cells
  • Oncology & Carcinogenesis
  • Multiple Myeloma
  • Medical Oncology
  • Humans
  • Bone Marrow
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis